Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2017 - PEPTIDE TECHNOLOGIES, INC. | form10q.htm |
| EX-32.2 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC. | exhibit32-2.htm |
| EX-31.2 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC. | exhibit31-2.htm |
| EX-31.1 - CERTIFICATION - PEPTIDE TECHNOLOGIES, INC. | exhibit31-1.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
In connection with the Quarterly Report of Eternelle Skincare Products Inc. (the ‘Company’) on Form 10-Q for the period ending June 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the ‘Report’), I, Baxter Koehn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Registrant | Eternelle Skincare Products Inc. | |
| Date : August 7, 2017 | By: | /s/ Baxter Koehn |
| Baxter Koehn | ||
| Chief Executive Officer and Chief Financial Officer | ||